• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Immunotherapy of ovarian cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin: effect of lymphadenectomy.卡介苗细胞壁骨架对卵巢癌的免疫治疗:淋巴结清扫术的影响
Cancer Sci. 2009 Oct;100(10):1991-5. doi: 10.1111/j.1349-7006.2009.01271.x. Epub 2009 Jul 1.
2
Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments.使用卡介苗细胞壁骨架(BCG-CWS)进行免疫辅助治疗晚期恶性肿瘤:安全性和免疫原性评估的1期研究。
Medicine (Baltimore). 2019 Aug;98(33):e16771. doi: 10.1097/MD.0000000000016771.
3
Gene-inducing program of human dendritic cells in response to BCG cell-wall skeleton (CWS), which reflects adjuvancy required for tumor immunotherapy.人树突状细胞响应卡介苗细胞壁骨架(CWS)的基因诱导程序,这反映了肿瘤免疫治疗所需的佐剂性。
Immunol Lett. 2005 May 15;98(2):280-90. doi: 10.1016/j.imlet.2004.12.002. Epub 2004 Dec 30.
4
Innate immune therapy with a Bacillus Calmette-Guérin cell wall skeleton after radical surgery for non-small cell lung cancer: a case-control study.非小细胞肺癌根治术后采用卡介苗细胞壁骨架进行的先天免疫治疗:一项病例对照研究。
Surg Today. 2009;39(3):194-200. doi: 10.1007/s00595-008-3826-3. Epub 2009 Mar 12.
5
Development of immunoadjuvants for immunotherapy of cancer.用于癌症免疫治疗的免疫佐剂的研发。
Int Immunopharmacol. 2001 Jul;1(7):1249-59. doi: 10.1016/s1567-5769(01)00055-8.
6
Mycobacterial cell-wall skeleton as a universal vaccine vehicle for antigen conjugation.分枝杆菌细胞壁骨架作为通用疫苗载体用于抗原偶联。
Vaccine. 2010 Nov 23;28(50):7873-80. doi: 10.1016/j.vaccine.2010.09.083. Epub 2010 Oct 23.
7
A retrospective study of immunotherapy using the cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin (BCG-CWS) for cervical cancer.牛型分枝杆菌细胞壁骨架(卡介苗-CWS)免疫治疗宫颈癌的回顾性研究。
Medicine (Baltimore). 2022 Dec 30;101(52):e32481. doi: 10.1097/MD.0000000000032481.
8
Does the cell wall skeleton from Bacille Calmette-Guérin directly induce interferon-gamma, independent of interleukin-12?卡介苗细胞壁骨架能否不依赖白细胞介素-12直接诱导γ干扰素?
Jpn J Clin Oncol. 1996 Jun;26(3):124-7. doi: 10.1093/oxfordjournals.jjco.a023194.
9
Application of BCG-CWS as a Systemic Adjuvant by Using Nanoparticulation Technology.BCG-CWS 通过纳米粒技术作为全身性佐剂的应用。
Mol Pharm. 2018 Dec 3;15(12):5762-5771. doi: 10.1021/acs.molpharmaceut.8b00919. Epub 2018 Nov 8.
10
Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.通过瘤内注射树突状细胞联合冷冻消融肿瘤预处理及卡介苗细胞壁骨架刺激增强免疫性肿瘤消退。
Clin Cancer Res. 2006 Dec 15;12(24):7465-75. doi: 10.1158/1078-0432.CCR-06-1840.

引用本文的文献

1
Revitalizing Bacillus Calmette-Guérin Immunotherapy for Bladder Cancer: Nanotechnology and Bioengineering Approaches.恢复卡介苗对膀胱癌的免疫治疗:纳米技术与生物工程方法
Pharmaceutics. 2024 Aug 15;16(8):1067. doi: 10.3390/pharmaceutics16081067.
2
Maintenance of homeostasis by TLR4 ligands.TLR4 配体对维持内稳态的作用。
Front Immunol. 2024 Apr 23;15:1286270. doi: 10.3389/fimmu.2024.1286270. eCollection 2024.
3
Exploiting bacterial-origin immunostimulants for improved vaccination and immunotherapy: current insights and future directions.利用源自细菌的免疫刺激剂改善疫苗接种和免疫治疗:当前见解与未来方向
Cell Biosci. 2024 Feb 17;14(1):24. doi: 10.1186/s13578-024-01207-7.
4
Culture filtrate proteins from BCG act as adjuvants for cytotoxic T lymphocyte induction.BCG 培养滤液蛋白作为细胞毒性 T 淋巴细胞诱导的佐剂。
Front Immunol. 2023 Oct 18;14:1271228. doi: 10.3389/fimmu.2023.1271228. eCollection 2023.
5
BCG Cell Wall Skeleton As a Vaccine Adjuvant Protects Both Infant and Old-Aged Mice from Influenza Virus Infection.卡介苗细胞壁骨架作为疫苗佐剂可保护幼龄和老龄小鼠免受流感病毒感染。
Biomedicines. 2021 May 5;9(5):516. doi: 10.3390/biomedicines9050516.
6
Mycobacteria-Based Vaccines as Immunotherapy for Non-urological Cancers.基于分枝杆菌的疫苗作为非泌尿系统癌症的免疫疗法
Cancers (Basel). 2020 Jul 5;12(7):1802. doi: 10.3390/cancers12071802.
7
Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments.使用卡介苗细胞壁骨架(BCG-CWS)进行免疫辅助治疗晚期恶性肿瘤:安全性和免疫原性评估的1期研究。
Medicine (Baltimore). 2019 Aug;98(33):e16771. doi: 10.1097/MD.0000000000016771.
8
Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer.纳米卡介苗:一种治疗人类膀胱癌的有前景的递送系统。
Front Pharmacol. 2018 Jan 12;8:977. doi: 10.3389/fphar.2017.00977. eCollection 2017.
9
BCG immunotherapy for bladder cancer--the effects of substrain differences.卡介苗免疫疗法治疗膀胱癌——亚种差异的影响。
Nat Rev Urol. 2013 Oct;10(10):580-8. doi: 10.1038/nrurol.2013.194. Epub 2013 Sep 17.
10
Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.研究观察:美国食品和药物管理局批准的用于癌症治疗的 Toll 样受体激动剂。
Oncoimmunology. 2012 Sep 1;1(6):894-907. doi: 10.4161/onci.20931.

本文引用的文献

1
Activation of Toll-like receptor 2 by a novel preparation of cell wall skeleton from Mycobacterium bovis BCG Tokyo (SMP-105) sufficiently enhances immune responses against tumors.来自东京卡介苗(SMP - 105)的新型细胞壁骨架制剂对Toll样受体2的激活充分增强了针对肿瘤的免疫反应。
Cancer Sci. 2008 Jul;99(7):1435-40. doi: 10.1111/j.1349-7006.2008.00832.x. Epub 2008 Apr 29.
2
Simultaneous blocking of human Toll-like receptors 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Guérin peptidoglycan.同时阻断人类Toll样受体2和4可抑制卡介苗肽聚糖诱导的髓样树突状细胞活化。
Infect Immun. 2003 Aug;71(8):4238-49. doi: 10.1128/IAI.71.8.4238-4249.2003.
3
Role of lymphadenectomy in ovarian cancer.淋巴结切除术在卵巢癌中的作用。
Best Pract Res Clin Obstet Gynaecol. 2002 Aug;16(4):529-51. doi: 10.1053/beog.2002.0301.
4
Value of lymph node assessment in ovarian cancer: Status of the art at the end of the second millennium.卵巢癌中淋巴结评估的价值:千年之交时的现状
Int J Gynecol Cancer. 2000 Nov;10(6):435-442. doi: 10.1046/j.1525-1438.2000.00053.x.
5
Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guérin: involvement of toll-like receptors.卡介苗细胞壁骨架诱导人树突状细胞成熟:Toll样受体的作用
Infect Immun. 2000 Dec;68(12):6883-90. doi: 10.1128/IAI.68.12.6883-6890.2000.
6
The instructive role of innate immunity in the acquired immune response.固有免疫在获得性免疫应答中的指导作用。
Science. 1996 Apr 5;272(5258):50-3. doi: 10.1126/science.272.5258.50.
7
Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin.用卡介苗牛型分枝杆菌细胞壁骨架进行肺癌的非特异性辅助免疫治疗。
Cancer Res. 1979 Aug;39(8):3262-7.
8
Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS).用卡介苗细胞壁骨架(BCG-CWS)对肺癌进行辅助免疫治疗。
Cancer. 1979 Apr;43(4):1314-9. doi: 10.1002/1097-0142(197904)43:4<1314::aid-cncr2820430420>3.0.co;2-6.

卡介苗细胞壁骨架对卵巢癌的免疫治疗:淋巴结清扫术的影响

Immunotherapy of ovarian cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin: effect of lymphadenectomy.

作者信息

Hayashi Akira, Nishida Yuichi, Yoshii Saiji, Kim Seo Young, Uda Hirotsugu, Hamasaki Toshimitsu

机构信息

CI Hayashi Immunotherapy Clinic and Research Institute, Osaka, Japan.

出版信息

Cancer Sci. 2009 Oct;100(10):1991-5. doi: 10.1111/j.1349-7006.2009.01271.x. Epub 2009 Jul 1.

DOI:10.1111/j.1349-7006.2009.01271.x
PMID:19656158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11159372/
Abstract

The significance of lymphadenectomy in surgery for various kinds of cancer has been widely debated, particularly in the gynecological field. The cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin (BCG-CWS) has been used as an effective adjuvant for immunotherapy of a variety of cancer patients. Here we tested the immunological importance of lymph nodes in treatment of ovarian cancer patients with BCG-CWS. After surgical removal of tumors, 73 ovarian cancer patients were intracutaneously inoculated with BCG-CWS in the antigen-unloaded state in the upper arm at 4-week intervals at a dosage of 2-200 microg. Significant correlation of lymphadenectomy and reduced survival of patients was observed (stages I, II, III, IV; hazard ratio 2.38, 95% confidence interval 1.02-5.12, Cox regression model). Lymphadenectomy also compromised with induction of interferon-gamma. In view of the importance of the role of lymph nodes in stimulation of Toll-like receptors by BCG-CWS, it is suggested that lymph nodes should be kept as much as possible to preserve the patient's immunity against cancer. Application of these results to surgery for other cancers should be considered.

摘要

淋巴结清扫术在各类癌症手术中的意义一直存在广泛争议,尤其是在妇科领域。卡介苗细胞壁骨架(BCG - CWS)已被用作多种癌症患者免疫治疗的有效佐剂。在此,我们测试了淋巴结在BCG - CWS治疗卵巢癌患者中的免疫重要性。手术切除肿瘤后,73例卵巢癌患者在上臂处于无抗原状态下,以2 - 200微克的剂量每隔4周进行一次BCG - CWS皮内接种。观察到淋巴结清扫术与患者生存率降低存在显著相关性(I、II、III、IV期;风险比2.38,95%置信区间1.02 - 5.12,Cox回归模型)。淋巴结清扫术还会影响干扰素 - γ的诱导。鉴于淋巴结在BCG - CWS刺激Toll样受体中的作用的重要性,建议尽可能保留淋巴结以维持患者对癌症的免疫力。应考虑将这些结果应用于其他癌症的手术。